In 2019, the Center for Drug Evaluation (CDE) of China reviewed and approved a total of 8730 drug registration applications. As a follow-up on part 3 of Drug Evaluation Report 2019, part 4 further gives an overview of new drug approvals for hot topics in drug therapy and major regulatory events/reforms of 2019 summarized by…
In the first quarter of 2020, the National Medical Products Administration (NMPA) approved a total of 11 new drugs including 6 imported drugs and 5 domestic drugs. Among them, domestic medicines also have a vaccine and a traditional Chinese medicine as the table below shows. Note: Here the NDAs are the drugs approved by NMPA…
On 2nd July, 2019, China CDE-NMPA published the 2018 working Report, summarizing the drug review and approval statistic data in the past year. See below for the details. 8- Statistic of Traditional Chinese Medicine – Overall 9- Statistic of Traditional Chinese Medicine -IND 10- Statistic of Traditional Chinese Medicine -NDA
On 2nd July, 2019, China CDE-NMPA published the 2018 working Report, summarizing the drug review and approval statistic data in the past year. See below for the details. 5- Statistic of Biological Products – Overall 6- Statistic of Biological Products -IND 7- Statistic of Biological Products -NDA
On 2nd July, 2019, China CDE-NMPA published the 2018 working Report, summarizing the drug review and approval statistic data in the past year. See below for the details. 1- Overall Statistic It can be seen from Figure 1, 2, 3 and 4, the backlog of drug applications in CDE has been greatly alleviated: the application…
